1 | 1820717-35-8 | 乙酸叔丁酯-一聚乙二醇-叠氮 | Azido-PEG1-CH2CO2tBu | C8H15N3O3
| 小分子PEG | |
2 | | N-ACETYLGLYCYLALANINEMETHYLAMIDE | N-ACETYLGLYCYLALANINEMETHYLAMIDE | C8H15N3O3
| | |
3 | | [2-(piperidin-3-yloxy)acetyl]urea | [2-(piperidin-3-yloxy)acetyl]urea | C8H15N3O3
| | |
4 | | 1-丁基-3-甲基咪唑硝酸盐,95% | 1-BUTYL-3-METHYLIMIDAZOLIUM NITRATE | C8H15N3O3
| | |
5 | 857802-41-6 | 2-(3-methylbutanamido)propanediamide | 2-(3-methylbutanamido)propanediamide | C8H15N3O3
| | |
6 | 43056-63-9 | 硝基呋喃代谢物AMOZ | 3-Amino-5-morpholinomethyl-2-oxazolidone | C8H15N3O3
| 中间体 - 医药中间体 | |
7 | 106693-44-1 | TERT-BUTYL 3-OXOPYRAZOLIDIN-4-YLCARBAMATE | TERT-BUTYL 3-OXOPYRAZOLIDIN-4-YLCARBAMATE | C8H15N3O3
| | |
8 | 705941-74-8 | 3-(4-Carbamoyl-piperazin-1-yl)-propionic acid | 3-(4-Carbamoyl-piperazin-1-yl)-propionic acid | C8H15N3O3
| | |
9 | | 3-AMINO-5-MORPHOLINOMETHYL-1,3OXAZOLIDONE >95% | 3-AMINO-5-MORPHOLINOMETHYL-1,3OXAZOLIDONE >95% | C8H15N3O3
| | |
10 | 1822581-31-6 | tert-butyl (1-amino-2-oxoazetidin-3-yl)carbamate | tert-butyl (1-amino-2-oxoazetidin-3-yl)carbamate | C8H15N3O3
| | |
11 | 14923-67-2 | ethyl (4E)-4-(carbamoylhydrazinylidene)pentanoate | ethyl (4E)-4-(carbamoylhydrazinylidene)pentanoate | C8H15N3O3
| | |
12 | | 4-(3-AMINO-PROPIONYL)-PIPERAZINE-1-CARBOXYLIC ACID | 4-(3-AMINO-PROPIONYL)-PIPERAZINE-1-CARBOXYLIC ACID | C8H15N3O3
| | |
13 | | 3-Amino-5-morpholinomethyl-1,3-oxazolidin-2-one >95% | 3-Amino-5-morpholinomethyl-1,3-oxazolidin-2-one >95% | C8H15N3O3
| | |
14 | 124553-01-1 | 1H-1,2,3-Triazole,1-(2,2-dimethoxyethyl)-5-ethoxy-(9CI) | 1H-1,2,3-Triazole,1-(2,2-dimethoxyethyl)-5-ethoxy-(9CI) | C8H15N3O3
| | |
15 | | methyl 2-{[2-(2-oxoimidazolidin-1-yl)ethyl]amino}acetate | methyl 2-{[2-(2-oxoimidazolidin-1-yl)ethyl]amino}acetate | C8H15N3O3
| | |
16 | 107347-90-0 | 精氨酸杂质 | 5-[[(DiMethylaMino)iMinoMethyl]aMino]-2-oxopentanoic Acid | C8H15N3O3
| | Aliphatics, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
17 | 1094299-57-6 | N-羟基-2-甲基-β-氧代-4-吗啉丙酰亚胺 | N'-hydroxy-3-(2-methylmorpholin-4-yl)-3-oxopropanimidamide | C8H15N3O3
| | |
18 | 1419723-92-4 | 5-[[(DiMethylaMino)iMinoMethyl]aMino]-2-oxopentanoic Acid-d6 | 5-[[(DiMethylaMino)iMinoMethyl]aMino]-2-oxopentanoic Acid-d6 | C8H15N3O3
| | Aliphatics, Isotope Labelled Compounds, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
19 | | 3-(3-amino-2-hydroxypropyl)-5,5-dimethylimidazolidine-2,4-dione | 3-(3-amino-2-hydroxypropyl)-5,5-dimethylimidazolidine-2,4-dione | C8H15N3O3
| | |
20 | 107347-91-1 | Pentanoic acid, 5-[[(methylamino)(methylimino)methyl]amino]-2-oxo- | Pentanoic acid, 5-[[(methylamino)(methylimino)methyl]amino]-2-oxo- | C8H15N3O3
| | |
21 | | 3-[2-hydroxy-3-(methylamino)propyl]-1-methylimidazolidine-2,4-dione | 3-[2-hydroxy-3-(methylamino)propyl]-1-methylimidazolidine-2,4-dione | C8H15N3O3
| | |
22 | 149049-86-5 | 2-Pyridinamine,6-ethoxy-1,4,5,6-tetrahydro-4-methyl-3-nitro-,cis-(9CI) | 2-Pyridinamine,6-ethoxy-1,4,5,6-tetrahydro-4-methyl-3-nitro-,cis-(9CI) | C8H15N3O3
| | |
23 | 149049-87-6 | 2-Pyridinamine,6-ethoxy-1,4,5,6-tetrahydro-4-methyl-3-nitro-,trans-(9CI) | 2-Pyridinamine,6-ethoxy-1,4,5,6-tetrahydro-4-methyl-3-nitro-,trans-(9CI) | C8H15N3O3
| | |
24 | 66501-18-6 | 3H-1,2,4-Triazol-3-one,5-ethoxy-1,2-dihydro-1-(2-methoxy-1-methylethyl)-(9CI) | 3H-1,2,4-Triazol-3-one,5-ethoxy-1,2-dihydro-1-(2-methoxy-1-methylethyl)-(9CI) | C8H15N3O3
| | |
25 | 94095-23-5 | 2,5-Furandione, mono-C24-28-alkenyl derivs., reaction products with diethylenetriamine | 2,5-Furandione, mono-C24-28-alkenyl derivs., reaction products with diethylenetriamine | C8H15N3O3
| | |
26 | 103170-35-0 | Urea, polymers with formaldehyde, phenol and sulfonated methylated phenol, ammonium salts | Urea, polymers with formaldehyde, phenol and sulfonated methylated phenol, ammonium salts | C8H15N3O3
| | |
27 | 49837-80-1 | 1-HYDROXY-4-[(HYDROXYIMINO)METHYL]-2,2,5,5-TETRAMETHYL-2,5-DIHYDRO-1H-IMIDAZOL-3-IUM-3-OLATE | 1-HYDROXY-4-[(HYDROXYIMINO)METHYL]-2,2,5,5-TETRAMETHYL-2,5-DIHYDRO-1H-IMIDAZOL-3-IUM-3-OLATE | C8H15N3O3
| | |